Cytokines in Cancer Immunotherapy

Cited by (504)

Items 401–500 of 504

1. Immunotherapy for high-grade endometrial stromal sarcoma: a narrative review bridging molecular insights to clinical translation
   Liubiqi Zhao, Yutong Su, Xiaoling Li, Fang Wang, He Li, Limei Fan, Lushuang Zhang · 2025 · Frontiers in Immunology
2. Introduction to the Immune System
   Scott McComb, Aude Thiriot, Bassel Akache, Lakshmi Krishnan, Felicity C. Stark · 2025 · Methods in molecular biology
3. Laminar double hydroxide-loaded miR-654-3p targets POU2F1-mediated metabolic reprogramming against colorectal cancer
   Jiwen Shi, Chengle Zhu, Shaopeng Xu, Ruorong Ran, Ruyin Ye, Yuhan Xiao, Yuxin Ji, Chenchen Geng, Guohui Tang, Ruonan Li et al. · 2025 · Bioorganic Chemistry
4. WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike “Non-Alpha” Muteins
   Christopher J. Nirschl, Kulandayan K. Subramanian, Heather R. Brodkin, Celesztina Domonkos, Connor J. Dwyer, Daniel J. Hicklin, RANDI E. ISAACS, Nesreen S. Ismail, Julie LePrevost, Yuka Lewis et al. · 2026 · Cancer Immunology Research
5. A modular platform for Sterically Masked Activated Cytokines (SMACks)
   Travis J. Morgenstern, Naruhisa Ota, Zhonghua Lin, Laura M. Lechermann, Herman S. Gill, Annie K. Ogasawara, Simon Williams, Kevin A. Marroquin, Alexis Scherl, C. Davies et al. · 2026 · Proceedings of the National Academy of Sciences
6. Innovative biomaterial solutions for enhancing the efficacy of tumor immunotherapy
   Pengwei Zhu · 2026 · Immunologic Research
7. Attenuated Salmonella carrying IL-21 expression plasmid enhances the efficacy of radiotherapy for hepatocellular carcinoma
   Jie Yang, Hanyu Jiang, Yujing Huang, Mingqiang Bao, Deqiang Zhang, Yijie Yan, Xinyi Li, Huijie Jia, 杨道坤, Tiesuo Zhao · 2026 · Journal of drug targeting
8. Comparative proteomics and metabolomics reveals distinct host protein quality control and metabolic signatures during recombinant IL1-His and IL15-His expression in Nicotiana benthamiana
   Alina Savinova, Theerakarn Srisangsung, Pipob Suwanchaikasem, Waranyoo Phoolcharoen · 2026 · PLoS ONE
9. Host-derived lactic acid disrupts IFN efficacy via antiviral inhibition and proinflammatory amplification
   Mingfu Tian, Siwei Chen, Ju Huang, Yan Hong Tan, Xuan Wang, Meng Li, Jianyong Zhu, Moran Li, Hongli Guo, Xu Li et al. · 2026 · Nature Communications
10. Cancer vaccines: translational strategies
    Hoyoung M. Maeng, Jay A. Berzofsky · 2021 · Elsevier eBooks
11. Neue Strategien für die onkologische Therapie: Interleukine im Fokus
    Jakob Jobst, Sebastian Kobold · 2021 · Deutsches Ärzteblatt
12. In silico investigation of a novel anti-EGFR scFv-IL-24 fusion protein induces apoptosis in malignant cells
    Zaroon Zaroon, Numan Yousaf, Shakira Aslam, Shahnila Qureshi, Hamid Bashir · 2023 · Journal of Molecular Modeling
13. IL-15 gene mutation as a molecular risk factor in acute lymphoblastic leukemia
    Sarbaz Ibrahim Mohammed, Kawa M. Hassan, Darya Mohammed Azeez, Fikry Ali Qadir, Abbas Burhan Salihi · 2024 · Cellular and Molecular Biology
14. In silico analysis of DEL-1 and inflammation-related genes in lung squamous cell carcinoma
    Rahşan Ilıkçı Sağkan, Dilara Fatma Akın, Recep Liman, Muhammad Muddassir Ali · 2024 · Immunobiology
15. Immune regulation and prognostic prediction model establishment and validation of PSMB6 in lung adenocarcinoma
    Haiyang Zhao, Kexin Luo, Meihan Liu, Yuanze Cai, Siman Liu, Shijuan Li, Yongsheng Zhao, Hongpan Zhang · 2024 · Frontiers in Genetics
16. Novel payloads of antibody-drug conjugates
    Yuxi Wang, Zhijia Wang, Ying Lu, Kunyu Shi, Jifa Zhang, Chengyong Wu · 2024 · Elsevier eBooks
17. Proteomic profiling of oral squamous cell carcinoma tissues reveals altered immune-related proteins: implications for personalized therapy
    Akhina Palollathil, Sreeranjini Babu, Chandran Sheela Abhinand, Rohan Thomas Mathew, Manavalan Vijayakumar, Thottethodi Subrahmanya Keshava Prasad · 2024 · Expert Review of Proteomics
18. Cancer Immunotherapy
    Javad Arabpour, Fatemeh Davodabadi, Manisha Nigam · 2025 · Interdisciplinary biotechnological advances
19. Immune System Modulations in Cancer Treatment: Nanoparticles in Immunotherapy
    Kadriye Kızılbey, Nelisa Türkoğlu, Fatma Ceren Kırmızıtaş · 2020 · IntechOpen eBooks
20. Immuno-modulating Mediators of Colon Cancer as Immuno-therapeutic: Mechanism and Potential
    Chanchal Kumar, Rajat Pratap Singh, Mrigendra Kumar Dwivedi, Ajay Amit · 2021 · Springer eBooks
21. Oncogenes Orchestrate Immunosuppressive Stroma in Gastric Adenocarcinoma
    Jiankang Jin, Shumei Song, Jaffer A. Ajani · 2020 · OBM Genetics
22. The Interdependence of Inflammation and ROS in Cancer
    Haijie Wu, Mingyue Zhong, Yuzhen Wang · 2021 · Springer eBooks
23. Identification of an Individualized Prognostic Biomarker for Serous Ovarian Cancer: A Qualitative Model
    Fengyuan Luo, Na Li, Qi Zhang, Liyuan Ma, Xinqiao Li, Tao Hu, Haijian Zhong, Hongdong Li, Guini Hong · 2022 · Diagnostics
24. Interleukin gene delivery for cancer gene therapy: In vitro and in vivo studies.
    Mohammad Amin Azimifar, Maryam Hashemi, Nahid Babaei, Zahra Salmasi, Abbas Doosti · 2023 · PubMed Central
25. Electroporation-mediated novel albumin-fused Flt3L DNA delivery promotes cDC1-associated anticancer immunity
    Ming‐Hung Hu, Darrell Fan, Hsin-Fang Tu, Ya-Chea Tsai, Liangmei He, Zhicheng Zhou, Michelle Cheng, Deyin Xing, Suyang Wang, Alexis Wu et al. · 2024 · Gene Therapy
26. Clinical characteristics, outcomes and follow-up of COVID-19 infection in cancer patients
    Minghao Fang, Jianmin Ling, Yanqing Wu, Zhaohua Wang, Le Yang · 2020
27. Editorial: Cytokine and cytokine receptor-based immunotherapies: Updates, controversies, challenges, and future perspectives
    Jun Wang, Brent Johnston, Pedro Berraondo · 2022 · Frontiers in Immunology
28. Role of Nanotechnology in Biological Therapies
    Blanca Ocampo‐García, Liliana Aranda‐Lara, Guillermina Ferro‐Flores, Enrique Morales-Ávila, Keila Isaac‐Olivé · 2022 · Wiley eBooks
29. Harnessing CAR T-Cells Against Breast Cancer: A Comprehensive Review
    Rajaram Vishnupriya, Thameena Dhasneem, Frank Arfuso, Asokan Balakrishnan Ramajayam, Sudha R. Warrier, Arun Dharmarajan · 2026 · Preprints.org
30. Development of Therapeutic Antibodies Against Carbonic Anhydrases
    Dovilė Stravinskienė, Aurelija Žvirblienė · 2019 · Springer eBooks
31. Cell and Immune Therapy
    Kevin Julio Wijanarko, Meijun Wang, Kwan Ting Chow · 2020 · Royal Society of Chemistry eBooks
32. Combination and integration to redirect NK cells for cancer immunotherapy
    Ying Gong · 2021
33. Kök hücreler kanser hücrelerinin mikroçevresindeki sitokin yanıtlarını etkiler: Meme kanseri ve dental pulpa kök hücreleri arasındaki etkileşim
    Sayra Dilmaç, Mustafa Gökhan Ertosun, Eda Açıkgöz, Gamze Tanrιöver · 2021 · Ege Tıp Dergisi
34. Immunotherapy for cancer treatment
    Kundan K. Rajak · 2022 · Elsevier eBooks
35. Eletrogeneterapia com IFN-Beta em modelo murino de melanoma
    Jean Carlos dos Santos da Luz · 2021 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
36. Toxins and Cancer Therapy
    Snook, Adam E. · 2021 · MDPI eBooks
37. The Interdependence of Inflammation and ROS in Cancer
    Haijie Wu, Mingyue Zhong, Yuzhen Wang · 2022 · Springer eBooks
38. The Impacts of Immunotherapy on Cancer
    Rachel M. Morris, Shayna N. Scott, Toni O. Mortimer, Abigail Schekall, Kim Leslie O'Neill · 2021 · Cancer Science & Research
39. Current Practice and Approaches of Immunotherapy in Cancer Treatment
    Akash Ahmed, Faiza Khondokar, Mahboob Hossain · 2022 · Asian Journal of Applied Sciences
40. Targeted delivery of low-dose liposomal STING agonist to CD103+ dendritic cells in tumor immunotherapy
    Aatman S. Doshi · 2021
41. Perspective Chapter: Liposome Mediated Delivery of Immunotherapeutics for Cancer
    Alessandra Iscaro, Faith Hannah Nutter Howard, Zidi Yang, Fern Jenkins, Munitta Muthana · 2022 · IntechOpen eBooks
42. Introduction on Personalized Immune-Oncology
    Banafshe Abadi, Nima Rezaei · 2022 · Springer eBooks
43. Fine-Tuning the Immune Response Against Cancer with Antibody-Cytokine Fusion Proteins
    Sol Ferrero, Matías Iván Gatto, Gustavo F. Helguera · 2023 · Springer eBooks
44. Advances in Peripheral Blood Biomarkers of Small Cell Lung Cancer
    丽萍 张 · 2023 · Advances in Clinical Medicine
45. Immunogenetics of Cancer
    Roberto Díaz‐Peña, Patricia Mondelo‐Macía, Patricia Garrido Castro · 2023 · Springer eBooks
46. Interleukin-27 Disrupts the Crosstalk of Apoptotic Activities between 4T1 Breast Cancer Cells and M2 Macrophages
    Nurliyana Mohd Yusof, Natasha Nur Afiqah Mohamed Noor Fuadi, Muhajir Hamid, Noorjahan Banu Alitheen, Nursyuhaida Mohd Hanafi, Nik Mohd Afizan Nik Abd Rahman · 2022 · Malaysian Journal of Medicine and Health Sciences
47. HED, a Human-Engineered Domain, Confers a Unique Fc-Binding Activity to Produce a New Class of Humanized Antibody-like Molecules
    Zhiqiang Zhu, Peeyush N. Goel, Zheng Cai, Yasuhiro Nagai, Lian Lam, Arabinda Samanta, Meiqing Ji, Hongtao Zhang, Mark I. Greene · 2023 · International Journal of Molecular Sciences
48. Data from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
    Lisa C. Wellinger, Simon J. Hogg, Dane M. Newman, Thomas Friess, Daniela Geiss, Jessica Michie, Kelly M. Ramsbottom, Marina Bacac, Tanja Fauti, Daniel Marbach et al. · 2023
49. Data from mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity
    Christopher J. Nirschl, Heather R. Brodkin, Celesztina Domonkos, Connor J. Dwyer, Daniel J. Hicklin, Nesreen S. Ismail, Cynthia Seidel‐Dugan, Philipp Steiner, Zoe Steuert, Jenna M. Sullivan et al. · 2023
50. The role of cellular immunity in the treatment of cancer
    Βασιλική Στραβοκεφάλου · 2023
51. Local Onco-Sphere: Tumor–Secretome Interaction
    Phei Er Saw, Erwei Song · 2023 · Springer eBooks
52. Combating Immunosuppression within Tumor Microenvironment: A Novel Approach for Drug Design
    Bhalchandra Mirlekar · 2019 · Open Access Journal of Cancer & Oncology
53. Cancer Therapy Using Lipid Nanoparticles to Encapsulate mRNA Mixtures Encoding Cytokines
    Zexi Li · 2024 · MedScien
54. CXCL7 plays a crucial role in facilitating extramedullary invasion and osteolytic damage in multiple myeloma
    Peng Liu, Yue Wang, Tianwei Lan, Chi Zhou · 2024 · Research Square
55. An Anti-CD138-Targeted Interferon-Alpha Has Broad Efficacy in Solid Tumors Through Direct Tumor Cell Killing and Intratumoral Immune Modulation
    Tahmineh Safaie, Kham R. Trinh, Alex Vasuthasawat, Sherie Leaver Morrison, David R. Stover · 2024 · Journal of Interferon & Cytokine Research
56. Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium
    Eric S. Schafer, Teresa Rushing, Kristine R. Crews, Colleen Annesley, Susan I. Colace, Nicole Kaiser, Lauren Pommert, Laura B. Ramsey, Himalee S. Sabnis, Kenneth K. Wong et al. · 2024 · JNCI Journal of the National Cancer Institute
57. Immunoadjuvants in Cancer Immunotherapy
    Mamta N. Talati, Neeraj Kumar Chouhan, Mani Sharma, Sripadi Hari Priya, Rajwinder Kaur · 2024 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
58. References
    2024 · Elsevier eBooks
59. Immunotherapy and immunomodulation in colorectal cancer treatment resistance
    Botle Precious Damane, Thanyani Victor Mulaudzi, Odisang Daniel Montwedi, Peace Mabeta, Shakeel Kader, William P. J. Leenders, Zodwa Dlamini · 2024 · Elsevier eBooks
60. Role of immunotherapy in cancer management
    Jeeja Mathummal Cherumanalil, Salwa Pannikkottuthodi, Jayakrishnan Thayyil · 2025 · International Journal of Basic & Clinical Pharmacology
61. Mapping the landscape of gastric cancer immunotherapy: Bibliometric insights into advances and hotspots
    Zhen Yuan, Jing-Hang Wang, Hao Cui, Shuyuan Wang, Bo Wei, Jianxin Cui · 2025 · World Journal of Gastrointestinal Oncology
62. Oncologia e Hematologia - Edição XI
    Guilherme Barroso L. De Freitas, Ana Flávia Palhares Resende · 2025
63. Breast Cancer Management and Systemic Therapies
    Hamda Khan, Safia Habib, Moinuddin Moinuddin · 2025 · Springer eBooks
64. Applications and prospects of synthetic receptors for therapeutic protein delivery
    Danhong Zhou, Yunxuan Chen, He Jin, Qinmeng Zhang, Zhiwei Jiang, Guoli Yang · 2025 · European Journal of Pharmaceutics and Biopharmaceutics
65. Enhanced efficacy of immune checkpoint inhibitors with OK‑432 in malignant pleural mesothelioma: A case report
    Kazuki Yamada, Takehiro Uemura, Aya Mukai, Tatsuya Tanaka, Ippei Sakakibara, Keima Ito, Yuta Mori, Kensuke Fukumitsu, Satoshi Fukuda, Yoshihiro Kanemitsu et al. · 2025 · Molecular and Clinical Oncology
66. Immunotherapy in Head and Neck Cancer
    Bridget E. Crossman, Regan L. Harmon, Mari Iida, Candie Y Lin, Jennifer R. Yoon, Evan P. Pisick, Ravi Salgia, Tiffany A. Glazer, Randall J. Kimple, Justine Y. Bruce et al. · 2025 · Cancer treatment and research
67. Investigating the correlation between cytokine levels and prognostic factors in advanced gastric cancer: A systematic review and meta-analysis
    Zakari Shaibu, Fumeng Yang, Zhihong Chen, Wei Zhu · 2025 · Cancer Treatment and Research Communications
68. Cytokine engineering for targeted immunotherapy
    Parisa Bakhshi, Jim Q. Ho, Nazanin Zaer, Thomas Jay Webster, Saeid Zanganeh · 2025 · Elsevier eBooks
69. Immunogenetics of Cancer
    Roberto Díaz‐Peña, Patricia Mondelo‐Macía, Patricia Garrido Castro · 2025 · Springer eBooks
70. Introduction on Personalized Immune-Oncology
    Banafshe Abadi, Nima Rezaei · 2025 · Springer eBooks
71. Fine-Tuning the Immune Response Against Cancer with Antibody-Cytokine Fusion Proteins
    Sol Ferrero, Matías Iván Gatto, Gustavo F. Helguera · 2025 · Springer eBooks
72. From Breakdown to Breakthrough: Immunoproteasomes Could Revolutionize Immunotherapies
    Cody A. Loy, Darci Jones Trader · 2025 · Journal of Medicinal Chemistry
73. Additional file 1 of Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal
    Wang, Zhenqing, Liang Chen, Ma, Yiqun, 李熙雷, Hu, Annan, Wang, Huiren, Wang, Wenxing, Li, Xiaomin, Tian, Bo, Dong, Jian · 2021 · Figshare
74. Additional file 3 of KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma
    Cui, Yankang, Shen, Tianyi, Xu, Feng, Zhang, Jing, Wang, Yuhao, Wu, Jiajin, Hengtao Bu, Fu, Dian, Fang, Bo, Huichen Lv et al. · 2022 · Figshare
75. Additional file 1 of In vivo tracking of adenoviral-transduced iron oxide-labeled bone marrow-derived dendritic cells using magnetic particle imaging
    Corby Fink, Julia J. Gevaert, John W. Barrett, Jimmy Dimitrios Dikeakos, Paula J. Foster, Gregory A. Dekaban · 2024 · Figshare
76. Additional file 2 of IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p
    Ehsan Gharib, Leili Rejali, Moein Piroozkhah, Elham Zonoobi, Parinaz Nasri Nasrabadi, Zahra Arabsorkhi, Kaveh Baghdar, Elahe Shams, Sadeghi, Amir, Kuppen, Peter J. K. et al. · 2024 · Figshare
77. Additional file 2 of KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma
    Cui, Yankang, Shen, Tianyi, Xu, Feng, Zhang, Jing, Wang, Yuhao, Wu, Jiajin, Hengtao Bu, Fu, Dian, Fang, Bo, Huichen Lv et al. · 2022 · Figshare
78. Additional file 1 of KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma
    Cui, Yankang, Shen, Tianyi, Xu, Feng, Zhang, Jing, Wang, Yuhao, Wu, Jiajin, Hengtao Bu, Fu, Dian, Fang, Bo, Huichen Lv et al. · 2022 · Figshare
79. Additional file 1 of Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives
    Xu, Huan, Mingyang Shi, Shao, Changsheng, Li, Hao, Wu, Jing, Yin Yu, Fang, Fang, Guo, Yugang, Xiao, Weihua · 2021 · Figshare
80. Additional file 1 of IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p
    Ehsan Gharib, Leili Rejali, Moein Piroozkhah, Elham Zonoobi, Parinaz Nasri Nasrabadi, Zahra Arabsorkhi, Kaveh Baghdar, Elahe Shams, Sadeghi, Amir, Kuppen, Peter J. K. et al. · 2024 · Figshare
81. Additional file 4 of KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma
    Cui, Yankang, Shen, Tianyi, Xu, Feng, Zhang, Jing, Wang, Yuhao, Wu, Jiajin, Hengtao Bu, Fu, Dian, Fang, Bo, Huichen Lv et al. · 2022 · Figshare
82. Crossroads between autoimmunity and cancer: underlying mechanisms and clinical implications
    Ada Gjyrezi, Charalampos Skarlis, Clio P. Mavragani, Paraskevi Giannakakou · 2025 · Physiological Reviews
83. Synthetic Biology Approaches for Cancer Immunotherapy Innovation
    Justin Dang, Brianna Przywozny, David De Zayas, Aman Syed · 2026 · Berkeley Pharma Tech Journal of Medicine
84. Towards Precision Oncology: How Advances in Cancer Genomics, Immunobiology and Artificial Intelligence Will Change Molecular Diagnostics
    Iyare Izevbaye · 2026 · Biomedicines
85. Mathematical Modeling of the Role of Cytokines in Sindbis Virus Treatment of Glioblastoma
    Shriya Makam, Hana M. Dobrovolny · 2026 · CPT Pharmacometrics & Systems Pharmacology
86. Prognostic Value of the Ratio of Interleukin-2 and Interleukin-10 in Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Therapy
    Deyuan Zhong, Yuxin Liang, Yuhao Su, Qinyan Yang, Hongtao Yan, Ying Shi, xiaolun Huang, Jin Shang · 2026 · Technology in Cancer Research & Treatment
87. Stem cells affect cytokine responses in the microenvironment of tumor cells: Interaction between breast cancer and dental pulp stem cells
    Sayra Dilmaç, Mustafa Gökhan Ertosun, Eda Açıkgöz, Gamze Tanrιöver · 2021 · DergiPark (Istanbul University)
88. In-depth Evaluation of the Olink Target 48 Cytokine Panel: Inter-Laboratory Evaluation of Performance and Reliability for Biomarker Studies in Oncology
    Yuhong Xiang, Chris Beaver, Zhenqiang Su, Dave Yeung, Jiejin Chen, Bin Li, Shawn Ciotti, Heather A. Myler · 2026 · The AAPS Journal
89. Cancer biology and the principles of targeted cancer drug discovery
    A. Davies, G. Jones, S. Krishnan, M. Krishnamoorthy, M. Maruggi, M. Kaneda, K. Marjon · 2026 · Elsevier eBooks
90. Identifying Cytokine Motif‐Containing, Immunomodulatory Bacterial Proteins in Human Gut Microbiome
    Ziyu Wang, Siqi Guo, Jing Li, Qianqian Huang, Jing Ning, Binbin Xia, Xun Lv, Xiang Liu, Zeyu Gao, Jine Li et al. · 2026 · Advanced Science
91. Integrated analysis and clinical impact of immune and stromal microenvironments in solid tumors
    Florent Petitprez · 2018 · theses.fr (ABES)
92. Validation de nouvelles cibles thérapeutiques dans le glioblastome par une approche de pharmacologie fonctionnelle
    Jérémy Ariey-Bonnet · 2020 · theses.fr (ABES)
93. Nouvelle approche en thérapie anti-tumorale : développement de nanovecteurs du calcitriol ciblant les macrophages
    Sabrina Nicolas · 2018 · theses.fr (ABES)
94. CD8+ T cell differentiation towards exhaustion in human cancer
    Christina Metoikidou · 2022 · theses.fr (ABES)
95. Intratumoral Delivery of mRNA for Cancer Immunotherapy: Progresses, Challenges, and Clinical Translation
    Uta Ishikawa, Moustafa T. Mabrouk, Yannan Yang · 2026 · ACS Nano Medicine
96. Advances in Interleukin-2 Engineering and Delivery Systems for Cancer Immunotherapy
    Xiaolei Du, Yuehua Chen, Min Xu, Hongyun Liu, J T Liu, Feihe Ma, Linqi Shi · 2026 · ACS Applied Bio Materials
97. Engineered Salmonella expressing IL-18 as a therapeutic strategy for colorectal cancer
    Talita Motta Quiarim, Bruna Dias de Lima Fragelli, Adilson Silva, Maria Teresa Marques Novo‐Mansur, Rebecca Kesselring, Fernanda F. Aníbal · 2026 · Research Square
98. Immune Checkpoint Molecules and Host Directed Therapy for Cancer Treatment
    Rahul Tiwari, Siddharth Sankar Singh, Vishal Kumar Singh, Vibhav Gautam, Rajiv Kumar · 2026 · Springer eBooks
99. Why JAK3 selectivity matters: biology, approved JAK inhibitors, and medicinal chemistry perspectives
    Sara Dias da Silva, R Parise-Filho · 2026 · Bioorganic Chemistry
100. Oncolytic Viruses: A Paradigm Shift in Cancer Treatment
     Amama Rani, Bonglee Kim · 2026 · Springer eBooks